Related Experiment Videos
Disseminated intravascular coagulation
1Department of Medicine, University of California, Los Angeles.
Insights
Disseminated intravascular coagulation (DIC) involves complex hemostasis system interactions. Understanding these pathophysiologic links is crucial for diagnosing and individually managing DIC, despite ongoing therapeutic controversies.
Area of Science:
- Hematology
- Pathophysiology
- Clinical Medicine
Background:
- Disseminated intravascular coagulation (DIC) presents with diverse clinical and laboratory findings.
- Understanding the hemostasis system's interrelationships is key to interpreting DIC manifestations.
- Many organ-specific syndromes share pathophysiology with DIC but are distinct entities.
Purpose of the Study:
- To present current concepts on the etiology, pathophysiology, diagnosis, and management of DIC.
- To highlight the importance of understanding pathophysiologic interrelationships in DIC.
- To discuss the individualized nature of DIC therapy.
Main Methods:
- Review of current concepts and literature on DIC.
- Emphasis on the interrelationships within the hemostasis system.
- Discussion of clinical and laboratory findings in DIC patients.
Main Results:
- Clinicians and scientists must understand pathophysiologic interrelationships to interpret DIC findings.
- Therapeutic decisions for DIC are often controversial and require individualization.
- DIC shares pathophysiology with various organ-specific syndromes.
Conclusions:
- A clear understanding of hemostasis is essential for diagnosing and managing DIC.
- Individualized therapy is paramount, considering patient-specific factors and DIC characteristics.
- Further research is needed on specific therapeutic modalities and survival patterns in DIC.
Abstract:
Current concepts of the etiology, pathophysiology, clinical and laboratory diagnosis, and management of fulminant and low-grade DIC have been presented. Considerable attention has been devoted to interrelationships within the hemostasis system. Only by clearly understanding these pathophysiologic interrelationships can the clinician and laboratory scientist appreciate the divergent and wide spectrum of often confusing clinical and laboratory findings in patients with DIC. Many therapeutic decisions to be made are controversial and will remain so until more is published about specific therapeutic modalities and survival patterns. Also, therapy must be highly individualized depending on the nature of DIC, age, etiology of DIC, site and severity of hemorrhage or thrombosis, and hemodynamic and other clinical parameters. Many syndromes that are organ-specific share common pathophysiology with DIC but are typically identified as an independent disease entity, such as hemolytic uremic syndrome, adult shock-lung syndrome, eclampsia, and many other isolated "organ-specific" disorders.